TSS
BCTXZ

Two Sigma Securities’s BriaCell Therapeutics Corp Warrant BCTXZ Stock Holding History

Two Sigma Securities’s Portfolio BCTXZ Stock Details BCTXZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43K Buy
+15,060
New +$1.47K ﹤0.01% 1618

Other funds holding BCTXZ

HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Two Sigma Securities's BCTXZ Position: Q2 2026 in Review

Two Sigma Securities opened a new position in BriaCell Therapeutics Corp Warrant (BCTXZ) in Q2 2026: 15,060 shares worth $1.43K. The stake represents ﹤0.01% of the portfolio and ranks #1618 among its holdings.

5 funds tracked by Wall St. Rank hold BCTXZ as of Q2 2026.

  • Two Sigma Securities held 15,060 shares of BriaCell Therapeutics Corp Warrant worth $1.43K as of Q2 2026.
  • BriaCell Therapeutics Corp Warrant was a new Two Sigma Securities position in Q2 2026.
  • BriaCell Therapeutics Corp Warrant made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1618 holding.
  • 5 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.